ASX Share rice
Thu 13 May 2021 - 02:00:pm (Sydney)

PAR Share Price

PARADIGM BIOPHARMACEUTICALS LIMITED..PARPharmaceuticals, Biotechnology & Life Sciences

PAR Company Information


Paradigm Biopharmaceuticals Limited





GIC Industry:


GIC Sub Industry:



500 Collins Street Melbourne VIC Australia 3000


61 3 9629 5566

CEO, MD & Exec. Chairman:

Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC

Chief Financial Officer:

Mr. Justin Cahill

Chief Operating Officer:

Dr. Jeannette Joughin

Chief Scientific Officer:

Dr. Ravi Krishnan

Director of Investor Relations:

Ms. Simon White

Global Head of Safety:

Dr. Michael Imperiale

Chief Medical Officer & Exec. Director:

Dr. Donna L. Skerrett

Commercial Head:

Ms. Beverley Huttmann

Global Head of Regulatory Affairs:

Ms. Michelle Coffey

Company Sec.:

Mr. Kevin G. Hollingsworth

Company Overview:

Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable form for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

PAR Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


PAR CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


PAR Income Statement

Income Date:


Income Before Tax:


Net Income:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


PAR Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Retained Earnings:


Other Liabilities:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


PAR Share Price History

PAR News

25 Apr, 2021
Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...
24 Jan, 2021
With the business potentially at an important milestone, we thought we'd take a closer look at Paradigm...
10 Dec, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
27 Oct, 2020
In this article we are going to estimate the intrinsic value of Paradigm Biopharmaceuticals Limited (ASX:PAR) by...
11 Sep, 2020
It might be of some concern to shareholders to see the Paradigm Biopharmaceuticals Limited (ASX:PAR) share price down...